Connect with us
Bioasis Technologies Inc. has recently announced partnerships for its xB3 pharmaceutical platform with Janssen Biotech and Nueramedy, along with the acquisition of Cresence AS' Epidermal Growth...
Satellos Bioscience is developing stem cell signaling pharmaceuticals that could reshape the way we treat muscular dystrophies like Duchenne muscular dystrophy (DMD). Its work is based...
Diversa's patented technology is based on lipid emulsions with an "easily controllable size and narrow distribution". These nanometer emulsions can associate a wide variety of compounds...
Moderna agreed to sell its coronavirus drug at a "pandemic price" of $32-37 per dose.The biotech company registered losses of $240 million in the first half...
Managed and owned by Bernard Tannoury, the Benta Pharma group has achieved sales of $77.5 million in 2019 and distributes its products in more than 40...
The company Varmx is developing an innovative drug for the treatment and prevention of severe bleeding in patients treated with oral anticoagulants. VarmX's most advanced product,...
The medical and diagnostic division of the Japanese technology giant will install a new MRI system at the Villarrobledo Hospital in Castilla-La Mancha. Canon was chosen...
Last year, the biotechnology sector in Switzerland grew again and proved to be a magnet for fresh capital and investment. The total number of employees in...
The shareholders and founders of “Biogenera”, a medium-sized biotech company, signed an agreement with “Life Care Capital”. Biogenera is a company that has created an internationally...
The young Graz-based company Innophore is conducting research for the "Chinese Center for Disease Control and Prevention" on molecules that bind parts of the coronavirus to...